Amaryllis Nucleics - Ownership and Business Overview

Life ScienceCompany

Amaryllis Nucleics Ownership

Who owns Amaryllis Nucleics?

Amaryllis Nucleics is owned by Active Motif. It was acquired on January 27, 2022.

Amaryllis Nucleics Business Overview

Where is Amaryllis Nucleics headquartered?

Amaryllis Nucleics is headquartered in Oakland, California.

What sector is Amaryllis Nucleics in?

Amaryllis Nucleics is a life science company.

When was Amaryllis Nucleics founded?

Amaryllis Nucleics was founded in 2016.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Amaryllis Nucleics

Amaryllis Nucleics

355 30th Street,
Oakland, California 94609
United States,
(415) 508-3230
www.amaryllisnucleics.com

Amaryllis Nucleics focused on proprietary RNA Sequencing methods. RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. Amaryllis Nucleics was founded in 2016 and is based in Oakland, California.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.